Cirsium arvense (L.) Scop.: Phytochemistry, Traditional Uses, Pharmacological Activities, and Future Therapeutic Potential

Plants, 2026

Full text Open access: Gold Metadata (CSL-JSON)
DOI 10.3390/plants15121835
Data confidence 85 high
How this score is calculated

It is built from checkable properties of the record itself: whether the article has a DOI, how many independent sources confirmed its data, whether the required fields are filled in, and how recent the latest confirmation is. Disagreement between sources and a missing identifier lower it. A value of 80 or above means the record was published without further checking; 60 to 79 means it is published at reduced confidence, with a manual check advisable. A record verified by an editor by hand is never pushed below 90 by a recalculation. This scores our data about the article, not the article itself.

Abstract

Cirsium arvense (L.) Scop is a perennial plant of the family Asteraceae that is mainly distributed in the temperate regions of the Northern Hemisphere. Despite being widely recognized as an invasive weed in agriculture, most of the scientific evidence shows its significant phytochemical and pharmacological importance. In the present review article, a comprehensive summary of the available literature on C. arvense’s botanical properties, phytochemical composition, biological activities, standardization potential, and future therapeutic prospects has been carefully provided. This plant has been used traditionally for the treatment of inflammation, infections, bleeding disorders, and liver-related disorders. Phytochemical investigations showed the presence of many bioactive compounds such as flavonoids, phenolic acids, triterpenes, sterols, tannins, glycosides, and volatile compounds. Among the reported biological activities, antioxidants and antimicrobial properties are the most studied activities. In addition, anticancer, antidiabetic, neuroprotective, anti-inflammatory, and antiproliferative activities have also been investigated. The environmental adaptability, rapid growth, and extensive root system of C. arvense highlight its potential for development as a sustainable medicinal and industrial crop. However, there are critical research gaps present in phytochemical standardization, toxicity assessment, pharmacokinetics, and clinical validation, warranting further comprehensive studies.